Thursday 17 July 2025

Pharma & Biotech Start-up & Scale-up News

Featured

Repare Therapeutics
A clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics.
Biotechnology
Biocytogen inks antibody deal with BeOne, expanding strategic ties
10 July 2025
article
IDEAYA exercises option for license on Biocytogen’s IDE034
11 November 2024

Latest Ones To Watch News

Biotechnology
One raises $16 million to accelerate tumor profiling platform
17 July 2025
Pharmaceutical
OncoZenge and Molteni amend BupiZenge project in Europe
17 July 2025
Biotechnology
BRIEF—Genascence receives FDA RMAT designation for GNSC-001
16 July 2025
More ones to watch news >
Reset all filters
Refine Search
Nanobiotix
Nanobiotix
Summit
Summit
MaaT Pharma
Nuvalent
UroGen Pharma
Tubulis
Neurocrine Biosciences
Axsome Therapeutics
Cidara Therapeutics
Halda Therapeutics
Opthea
OncoZenge
Soleno Therapeutics
GAIA
Alligator Bioscience
Pliant Therapeutics
Nuvation Bio
Enanta Pharmaceuticals
Basilea
Exsilio Therapeutics


Today's issue

Kowa and Nicox sign further deal over glaucoma treatment
Pharmaceutical
Kowa and Nicox sign further deal over glaucoma treatment
17 July 2025
Pharmaceutical
Allen Institute and ASAP to work on expanding brain cell atlas
17 July 2025
Biotechnology
One raises $16 million to accelerate tumor profiling platform
17 July 2025
Pharmaceutical
BMS and Pfizer announce direct-to-patient Eliquis option
17 July 2025
Biotechnology
Innovator and biosimilar drug approvals in 2024 down on prior year
17 July 2025
Pharmaceutical
Grifols to invest 160M euros in new manufacturing site
17 July 2025
Biotechnology
SandboxAQ and iOncologi link up on mRNA vaccine for glioblastoma
17 July 2025

Company Spotlight

A clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics.




Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze